HEMASURE INC
10-Q, EX-27, 2000-08-11
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: HEMASURE INC, 10-Q, EX-10.33, 2000-08-11
Next: METACREATIONS CORP, NT 10-Q, 2000-08-11



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM  THE
FINANCIAL  STATEMENTS  OF HEMASURE INC. FOR THE SIX MONTHS ENDED JUNE 30, 2000
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<MULTIPLIER>                                               1,000
<CURRENCY>                                          U.S. DOLLARS

<S>                                                  <C>
<PERIOD-TYPE>                                              6-MOS
<FISCAL-YEAR-END>                                    DEC-31-2000
<PERIOD-START>                                       JAN-01-2000
<PERIOD-END>                                         JUN-30-2000
<EXCHANGE-RATE>                                                1
<CASH>                                                     7,535
<SECURITIES>                                              14,846
<RECEIVABLES>                                                264
<ALLOWANCES>                                                  36
<INVENTORY>                                                3,357
<CURRENT-ASSETS>                                          26,609
<PP&E>                                                     4,829
<DEPRECIATION>                                             2,632
<TOTAL-ASSETS>                                            28,856
<CURRENT-LIABILITIES>                                      8,093
<BONDS>                                                        0
<COMMON>                                                     197
                                          0
                                                    0
<OTHER-SE>                                                20,539
<TOTAL-LIABILITY-AND-EQUITY>                              28,856
<SALES>                                                    2,459
<TOTAL-REVENUES>                                           2,459
<CGS>                                                      3,401
<TOTAL-COSTS>                                              3,401
<OTHER-EXPENSES>                                           5,442
<LOSS-PROVISION>                                               0
<INTEREST-EXPENSE>                                         (754)
<INCOME-PRETAX>                                          (6,665)
<INCOME-TAX>                                                   0
<INCOME-CONTINUING>                                      (6,665)
<DISCONTINUED>                                                 0
<EXTRAORDINARY>                                                0
<CHANGES>                                                      0
<NET-INCOME>                                             (6,665)
<EPS-BASIC>                                               (0.36)
<EPS-DILUTED>                                                  0



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission